|1.||Miyashita, Kazuo: 5 articles (08/2015 - 01/2006)|
|2.||Hosokawa, Masashi: 5 articles (08/2015 - 01/2006)|
|3.||Mori, Naoki: 4 articles (10/2013 - 12/2008)|
|4.||Yasumoto, Takeshi: 4 articles (10/2013 - 12/2008)|
|5.||Ishikawa, Chie: 4 articles (10/2013 - 12/2008)|
|6.||Martin, Luc J: 3 articles (08/2015 - 06/2014)|
|7.||Mamelona, Jean: 2 articles (01/2015 - 06/2014)|
|8.||Rwigemera, Arlette: 2 articles (01/2015 - 06/2014)|
|9.||Tafuku, Senji: 2 articles (10/2012 - 12/2008)|
|10.||Kodate, Mei: 1 article (08/2015)|
|1.||Breast Neoplasms (Breast Cancer)
01/01/2015 - "Fucoxanthinol and fucoxanthin could be effective for the treatment and/or prevention of breast cancer."
01/01/2015 - "Comparative effects between fucoxanthinol and its precursor fucoxanthin on viability and apoptosis of breast cancer cell lines MCF-7 and MDA-MB-231."
06/01/2014 - "Inhibitory effects of fucoxanthinol on the viability of human breast cancer cell lines MCF-7 and MDA-MB-231 are correlated with modulation of the NF-kappaB pathway."
06/01/2014 - "Taken together, the current results suggest that fucoxanthinol and fucoxanthin could be potentially effective for the treatment and/or prevention of different types of cancers, including breast cancer. "
01/01/2006 - "Furthermore, halocynthiaxanthin and fucoxanthinol induced apoptosis in HL-60 cells, MCF-7 human breast cancer cells, and Caco-2 human colon cancer cells. "
12/01/2008 - "Mice with severe combined immunodeficiency harboring tumors induced by inoculation of HTLV-1-infected T cells responded to treatment with fucoxanthinol with suppression of tumor growth, showed extensive tissue distribution of fucoxanthinol, and the presence of therapeutically effective serum concentrations of fucoxanthinol. "
08/01/2015 - "In this review, we address the mechanisms of action of fucoxanthin and fucoxanthinol according to different types of cancers. "
08/01/2015 - "In every cancer tested, modulatory actions of fucoxanthinol on viability, cell-cycle arrest, apoptosis and members of the NF-κB pathway were more pronounced than that of fucoxanthin. "
08/01/2015 - "Fucoxanthin and Its Metabolite Fucoxanthinol in Cancer Prevention and Treatment."
12/01/2013 - "The anti-cancer effect of fucoxanthin and its deacetylated metabolite, fucoxanthinol, is well documented. "
|3.||Hodgkin Disease (Hodgkin's Disease)
10/01/2012 - " This study explored the effects of FX and its deacetylated product, fucoxanthinol (FXOH), on B-cell malignancies, including Burkitt's lymphoma, Hodgkin's lymphoma and Epstein-Barr virus-immortalized B cells. "
10/01/2012 - "Anti-neoplastic effects of fucoxanthin and its deacetylated product, fucoxanthinol, on Burkitt's and Hodgkin's lymphoma cells."
|4.||Burkitt Lymphoma (Burkitt's Lymphoma)
06/01/2010 - "Fucoxanthin isolated from edible seaweeds and its metabolite fucoxanthinol have been recently found to have anti-obesity effects, but the mechanism is not fully understood. "
08/01/2015 - "Fucoxanthinol, Metabolite of Fucoxanthin, Improves Obesity-Induced Inflammation in Adipocyte Cells."
|3.||Transcription Factor AP-1 (Transcription Factor AP 1)
|4.||SOX9 Transcription Factor
|6.||NF-kappa B (NF-kB)
|7.||Proteins (Proteins, Gene)
|8.||Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)